We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 3,942

The Danish government plans to regulate prices for medicines: a brand new pricing regime is proposed
  • Accura Advokatpartnerselskab
  • Denmark
  • November 12 2018

Under the current Danish legislation, the product pricing of medicinal companies is unregulated by law. This is true both for medicinal products sold

Introduction of seven day timeframe for termination payments in Modern Awards
  • Maddocks
  • Australia
  • November 8 2018

From 1 November 2018 the following model clause takes effect in 89 of the 122 modern awards: Payment on termination of employment The employer must

Patent enforcement through the courts in Mexico
  • Mexico, Global
  • November 7 2018

A structured guide to enforcing patents through the courts in Mexico

New Delaware Chapter 11 Filing - Egalet Corporation
  • Cole Schotz PC
  • USA
  • October 31 2018

Egalet Corporation (OCTQX: EGLT), along with two of its affiliates and subsidiaries, has filed a petition for relief under chapter 11 in the

How SUPPORT Will Affect Pharma Interactions With DEA
  • Cadwalader Wickersham & Taft LLP
  • USA
  • October 31 2018

The opioid package President Donald Trump signed last week garnered much attention. While it is largely directed at treatment and prevention, it

Taking the Medicine
  • VdA
  • Portugal
  • October 31 2018

Portugal's new Medicine Act has come into effect at a time of good health for Portugal's life sciences sector

How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline
  • Rothwell, Figg, Ernst & Manbeck, PC
  • USA, European Union
  • October 29 2018

As pharmaceutical drug costs attract increasing media attention and political scrutiny, a growing number of biosimilar drugs are set to enter the U.S

Trump touts “historic” plan to overhaul Medicare payments, create International Pricing Index
  • Hogan Lovells
  • USA
  • October 25 2018

President Trump today touted “bold” plans to lower drug prices in unspecific terms. Simultaneously, CMS issued an Advance Notice of Proposed

New Law Requires Disclosure of Biologic Patent Settlement Agreements to Antitrust Authorities
  • Jones Day
  • USA
  • October 17 2018

Last week, the Patient Right to Know Drug Prices Act ("Act") became law. The Act requires pharmaceutical companies to disclose to antitrust agencies

Was gilt, wenn OTC zu Rx werden? Folgen der Aufhebung der Kategorie C
  • Streichenberg Attorneys at Law
  • Switzerland
  • October 16 2018

Die Kategorie der apothekenpflichtigen Arzneimittel wird aufgehoben (bisherige Abgabekategorie C). Na...